echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > To build a "precision prevention and control" model, Tianjin Cancer Hospital set up a liver cancer prevention and control research center.

    To build a "precision prevention and control" model, Tianjin Cancer Hospital set up a liver cancer prevention and control research center.

    • Last Update: 2020-08-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Recently, the "Liver Cancer Prevention and Control Research Center" and the National Health and Health Administration Hospital Management Institute ,"a standardized training project demonstration project for primary liver cancer diagnosis and treatment" was established at Tianjin Medical University Cancer Hospital.
    China is a major liver cancer country, with about 59% of new cases worldwide each year. Although new treatments such as targeted drugs and immunotherapy have brought more solutions to the treatment of liver cancer, the progress of liver cancer treatment is still slow. At present, the diagnosis and treatment of liver cancer still faces the difficulty of early diagnosis, high rate of recurrence metastasis, radiation chemotherapy tolerance and lack of effective treatment targets. Therefore, it is of great significance to establish a research center for liver cancer prevention and treatment in one integrated basic research, applied research, technological innovation and product development.
    "Liver Cancer Prevention and Control Research Center" relying on the Tianjin Medical University Cancer Hospital discipline platform, patient-centered, in order to achieve liver cancer prevention and early diagnosis and individualization, standardized multidisciplinary consultation and treatment (MDT) as the goal, to create a "precision prevention and treatment" model of liver cancer, so that patients in a short period of time to obtain individual treatment options.At the same time,
    the center will closely combine basic research, transformation al-china research and clinical research on liver cancer, build an innovative mechanism of close cooperation between production, learning and research, and build a new system for the transformation of comprehensive prevention and treatment of liver cancer, so as to realize the real application of scientific research results to the clinic.Professor Lu Wei, party secretary of Tianjin Medical University Cancer Hospital and director of the Liver Cancer Prevention and Control Research Center, said, "The Center for The Prevention and Control of Liver Cancer" will focus on the goal of "reducing the incidence and mortality of liver cancer in China" and carry out high-level basic and clinical application research in the areas including early diagnosis and prognosis of liver cancer, immunotherapy of liver cancer, molecular control network of liver cancer, and clinical data analysis of liver cancer.

    Professor Song Tianqiang, director of the Department of Hepatobiliary Oncology at Tianjin Medical University Cancer Hospital and executive director of the Center for The Prevention and Control of Liver Cancer, also expressed the need to further strengthen the close cooperation of the departments of liver cancer-related clinics such as surgery, intervention, internal medicine, radiotherapy, ultrasound, pathology and imaging. At the same time, we will strengthen the popular science publicity for the prevention and treatment of liver cancer, establish and promote the "prevention-diagnosis-treatment" planning management system for liver cancer, and enhance the public's awareness of liver cancer.
    in addition, the standardized training project for primary liver cancer diagnosis and treatment in 2018 by the National Health and Care Commission Hospital Management Research Institute, through the "primary liver cancer diagnosis and treatment norms (2017 edition)" publicity and training, to promote medical institutions in accordance with the requirements of the norms, master standardized means of diagnosis and treatment, to provide patients with standardized medical services.
    project will establish 10 standardized diagnosis and treatment demonstration bases and more than 20 test bases nationwide from 2018 to 2019. Tianjin Medical University Cancer Hospital, as a demonstration base, will, through demonstration effect, to demonstration teaching, academic seminars, network exchanges and other forms, to drive and affect the demonstration base around the medical institutions of liver cancer standardization diagnosis and treatment work, improve the medical personnel's ability to diagnose and treat. (Tianjin Cancer Hospital Yang Yang)
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.